Skip to main content
. 2022 Oct 28;43:110. doi: 10.11604/pamj.2022.43.110.34390

Table 2.

preeclampsia prevalence by HIV-serostatus among women admitted to Women and Newborn Hospital

Characteristic Level HIV seronegative N=216 (87.5%) HIV seropositive N=31 (12.6%)
n (%) 95% CI n (%) 95% CI
Age (years) 14-24 50(23.5) 17.9-29.7 9(30.0) 14.7-49.4
25-34 102(47.9) 41.0-54.8 16(53.3) 34.3-71.7
≥35 61(28.6) 22.7-35.2 5(16.7) 5.6-34.7
Parity 1 67(32.7) 26.3-39.6 8(28.6) 13.2-48.7
2-4 106(51.7) 44.6-58.7 16(57.1) 37.2-75.5
≥5 32(15.6) 10.9-21.3 4(14.3) 4.0-32.0
Gravidity 1 65(30.5) 24.4-37.2 9(29.0) 14.2-48.0
2 45(21.1) 15.9-27.2 5(16.1) 5.5-33.7
> 2 103(48.4) 41.5-55.3 17(54.8) 36.0-72.7
Employment status Unemployed 150(87.2) 81.3-91.8 21(87.5) 67.6-97.3
Employed 22(12.8) 8.2-18.7 3(12.5) 2.7-32.4
ANC attendance No 2(0.9) 0.1-3.3 1(3.2) 0.1-16.7
Yes 214(99.1) 96.7-99.9 30(96.8) 83.3-99.9
Substance use (alcohol, smoking) No 215(99.5) 97.5-99.9 31(100) 88.8-100*
Yes 1(0.5) 0.1-2.6 - -

Key: *=one-sided; 97.5% confidence interval; ANC-antenatal care; PE-pre-eclampsia; HIV- human immunodeficiency virus